The Anticoagulation Forum publishes 3-4 newsletters annually. Content from our newsletters is put on our Web site as a way to share information for the mutual growth and development of professionals in the anticoagulation field.
Winter 2008
This edition of the newsletter contains an informative article entitled Emerging Anticoagulants in the Management of Venous Thromboembolism by Dr. Alex Spyropoulos. Other articles include a new edition of Anticoagulation Updates from the Literature, updates from NATT and NCBAP, and the AC Forum’s new address and contact information.Fall 2007
This Anticoagulation Forum newsletter includes a copy of the letter sent to the Centers for Medicare and Medicaid Services in support of expanded coverage for patient self-testing, announces NATT's large grant from the CDC, and includes a chart outlining the many organizations working in the field of thrombosis.Summer 2007
This issue of the newsletter includes a letter from the AC Forum Board of Directors to Dr. Lawrence Lesko, Director, Office of Clinical Pharmacology at the FDA. The letter outlines the AC Forum's concerns about the FDA's plan to add information about genotype testing to the warfarin package insert. The newsletter also includes Dr. Lesko's response letter.Winter 2007
The Anticoagulation Forum’s 9th National Conference on May 3-5 in Chicago is just a few months away. Be sure to register soon. Dr. Jack Ansell steps down as president and Dr. David Garcia introduces his vision for the AC Forum’s future. Also included is a commentary by Mark Crowther, MD on “Fixed-Dose Unfractionated Heparin for the Treatment of Venous Thromboembolism”.Fall 2006
Register soon for the 9th National Conference on Anticoagulation Therapy. The newsletter has information on the Anticoagulation Forum's conference is being held in Chicago in May 2007. Also in this newsletter, read an article on venous thromboembolism prophylaxis in the hospitalized medically-ill patient by Dr. Geno Merli, updates on NCBAP and NATT, and information on the link between air travel and DVT.Spring 2006
This issue features a study investigating the interaction between cranberry juice and warfarin, introduces new members of the AC Forum Board of Directors, and offers free copies of the 8th National Conference proceeding published by the Journal of Thrombosis and Thrombolysis.Fall 2005
This issue announces that Chicago will be the site for the next Anticoagulation Forum conference - May 3-5, 2007. Also included is an article on "Understanding the Variability of Warfarin Dosing" and updates from the National Alliance on Thrombosis and Thrombophilia (NATT) and from the National Certification Board of Anticoagulation Providers (NCBAP) including a list of the newest CACPs.Spring 2005
The 8th National Conference is just 2 months away. Please view the newsletter for more details. Also in this issue, Dr. Jack Ansell discusses "What Happened to Ximelagatran?" Read updates from the National Alliance for Thrombosis and Thrombophilia, the National Certification Board of Anticoagulation Providers (including information on the recertification process) and information from the NIH conference on Dietary Supplements, Coagulation, and Antithrombotic Therapies.Fall 2004
This edition contains new information on long-term, secondary treatment of deep venous thrombosis, a CACP credentialing update as well as details on a National Consumers League campaign to improve senior outpatient medication safety.Spring 2004
Read our expanded newsletter with articles on Perioperative Management of Oral Anticoagulation, Anticoagulants used in the HIT Positive Patient, CACP information, Patient Advocacy Initiatives and a save the date reminder for our 8th National Conference.Fall 2003
Patient Advocacy in INR Self-Monitoring - read about European success stories as well as how your patients can get involved in lobbying for improved reimbursement of patient self-monitoring.Summer 2003
Congratulations to our newest CACPs! - The National Certification Board for Anticoagulation Providers (NCBAP) is pleased to announce the most recent recipients of the CACP credential.Spring 2003
7th National Conference - The Anticoagulation Forum’s 7th National Conference on Anticoagulant Therapy, May 8-10, 2003, in San Francisco, CA is just around the corner.Fall 2002
Pharmacogenomics of Warfarin - Pharmacogenomics is a rapidly expanding field that refers to the impact of genetic expression on drug response.Spring 2002
The Anticoagulation Forum's 7th National Conference on Anticoagulation is being held in San Francisco May 8 - 10 2003Fall 2001
The Anticoagulation Forum held its sixth National Conference on Anticoagulant Therapy May 10-12, 2001, in Washington, D.C. The meeting attracted over 600 participants representing the nursing, pharmacy and medical professions.Spring 2001
This issue's features include: The 6th National Conference Update, Congratulations to the Latest CACP Recipients, Risk Factors in Pregnant Patients with VTE and Internet Based Eductaion - An Update on USI Anticoagulation Management Program.Fall 2000
The ACF's 6th National Conference on Anticoagulant Therapy will be held in Washington, D.C. May 10-12, 2001. An International panel of speakers will discuss new anticoagulant drugs, advances in the diagnosis of venous thromboembolism, accuracy precision and quality control for point-of-care testing as well a wide range of topics focusing on the management and administration of anticoagulation therapy.Spring 2000
Washington, DC to be Site of 6th National ACF Conference; Recent Advances in Venous Thrombosis, Pulmonary Embolism & Anticoagulation Therapy: From A to V Leiden; Cardiac Surgical Advances in Anticoagulant Therapy Management: The INRange Monitored Heart Valve; Certified Anticoagulant Care Provider (CACP) Exam; ACCP 6th Consensus Conference Meets